Oxitec

Abingdon, United Kingdom Founded: 2002 • Age: 24 yrs Acquired By Precigen
Genetically modified insects are developed to suppress pest populations.
Annual revenue $1.5M Latest available
Total funding $26.4M 10 rounds
Employees 78 Tracked headcount
Investors 6 Known backers
Products 5 Services tracked
Competitors 9 Brand Intelligence

About Oxitec

Oxitec is a company based in Abingdon (United Kingdom) founded in 2002 was acquired by Precigen in August 2015. Oxitec has raised $26.43 million across 10 funding rounds from investors including Gates Foundation, Precigen and Wellcome. The company has 78 employees as of December 31, 2021. Oxitec offers products and services including Friendly™ Aedes Program, Friendly™ Fall Armyworm, Friendly™ Cattle Tick, Friendly™ Soybean Looper, and Friendly™ Mediterranean Fruit Fly. Oxitec operates in a competitive market with competitors including BioPhero, Bee Vectoring Tech, Beneficial Insectary, Agrobio and Phyllom BioProducts, among others.

  • Headquarter Abingdon, United Kingdom
  • Employees 78 as on 31 Dec, 2021
  • Sectors
    Agriculture
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Oxitec Limited
  • Date of Incorporation 15 Aug, 2002
  • Jurisdiction ABINGDON, OXFORDSHIRE, ENGLAND
Operational Areas
Agriculture → Agricultural Technology & Innovation Unlock Sub-Sector Unlock Segment
Agriculture → Agricultural Technology & Innovation Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $1.55 M (USD)
    315
    as on Dec 31, 2016
  • Net Profit
    -$7.65 M (USD)
    17
    as on Dec 31, 2016
  • EBITDA
    Not available
  • Total Equity Funding
    $26.43 M (USD)

    in 10 rounds

  • Latest Funding Round
    $18 M (USD), Grant

    Apr 20, 2022

  • Investors
  • Employee Count
    78

    as on Dec 31, 2021

  • Acquired by
    Precigen

    (Aug 10, 2015)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Oxitec

Oxitec offers a comprehensive portfolio of products and services, including Friendly™ Aedes Program, Friendly™ Fall Armyworm, Friendly™ Cattle Tick, Friendly™ Soybean Looper, and Friendly™ Mediterranean Fruit Fly.

Product name locked
Category locked
Primary

Biological method to control Aedes mosquitoes transmitting diseases like dengue.

Product name locked
Category locked
Locked

Technology to manage fall armyworm pests damaging global crops.

Product name locked
Category locked
Locked

Solution for controlling ticks that harm livestock and spread diseases.

Product name locked
Category locked
Locked

Program to reduce soybean looper pests affecting agricultural yields.

Product name locked
Category locked
Locked

Biological control for fruit flies impacting orchards and food production.

People of Oxitec

Headcount 50-200
Employee Profiles 32
Employee Profiles
People
Thomas Mabey
Group Lead
People
Matilda Hewitt
Group Lead
People
Scott James Gourlay
Scientist
People
Leigh Thomas
Research Scientist

Unlock access to complete

Funding Insights of Oxitec

Oxitec has successfully raised a total of $26.43M across 10 strategic funding rounds. The most recent funding activity was a Grant round of $18 million completed in April 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in Oxitec

Oxitec has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Gates Foundation, Precigen and Wellcome.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Early-stage venture capital is invested in UK technology sectors.
Locked Locked Locked
-
Locked Locked Locked
Charitable foundation investments on poverty reduction and healthcare
Locked Locked Locked
Premium access

Investor details for Oxitec

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Oxitec

Investments
Premium access

Investment portfolio details for Oxitec

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Oxitec

Premium access

Detailed financials for Oxitec

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Oxitec Comparisons

Oxitec Primary company
Description
Genetically modified insects are developed to suppress pest ...
Location
Abingdon, United Kingdom
Founded Year
2002
Annual Revenue
$1.55 M (USD)
Net Profit
-$7.65 M (USD)
EBITDA
Not available
Employees
78
As of 2021
Premium access

Peer comparison for Oxitec

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Oxitec

Oxitec operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BioPhero, Bee Vectoring Tech, Beneficial Insectary, Agrobio and Phyllom BioProducts, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Insect pheromones for pest management are produced and supplied.
Locked Locked Locked
Bee vectoring technology is developed for organic plant protection.
Locked Locked Locked
Beneficial insects and mites are mass-produced for agricultural pest control.
Locked Locked Locked
Agrobio is engaged in biological pest control and pollination.
Locked Locked Locked
Producer and supplier of biological pest control agents
Premium access

Detailed competitors of Oxitec

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Oxitec

Premium access

Complete news archive for Oxitec

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Oxitec

Oxitec was founded in 2002.

Oxitec is headquartered in Abingdon, United Kingdom. It is registered at Abingdon, Oxfordshire, United Kingdom.

Grey Frandsen is the current CEO of Oxitec.

Oxitec is a funded company, having raised a total of $26.43M across 10 funding rounds to date.

As of Dec 31, 2021, the latest employee count at Oxitec is 78.

Annual revenue of Oxitec is $1.55M as on Dec 31, 2016.

Oxitec was founded in 2002 in Abingdon, United Kingdom, and operates in the biotechnology sector. Genetically modified insects are created by the company to reduce pest populations through targeted releases. Services are provided primarily to governments in developing countries, with a business model based on recurring payments for periodic insect deployments. Operations focus on sustainable pest control methods without broad environmental impacts.

Oxitec's top competitors include Bee Vectoring Tech, BioPhero and Beneficial Insectary.

Oxitec offers Friendly™ Aedes Program, Friendly™ Fall Armyworm, Friendly™ Cattle Tick, Friendly™ Soybean Looper, and Friendly™ Mediterranean Fruit Fly.

Oxitec has 6 investors. Key investors include Gates Foundation, Precigen, Wellcome, Oxford Capital, and East Hill Management Company.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available